Founded | 2008 |
---|---|
Founder | Valerie Guild Jean Schlipmann |
Location |
|
Key people | Valerie Guild Jean Schlipmann |
Website | http://AIMatMelanoma.org |
The AIM at Melanoma Foundation (AIM) is a nonprofit organization focused on melanoma research.[1]
AIM was created as a collaboration between the Charlie Guild Foundation and James A. Schlipmann Melanoma Cancer Foundation.[2]
Activities
AIM is a partner of the Society for Immunotherapy of Cancer.[3]
Sponsors
In the first quarter of 2021, the foundation received a $10,000 grant from Pfizer for a project titled “From the Clinic to the Living Room”.[4] Additional industry sponsors include:[5]
References
- ↑ "About". Aim at Melanoma. Retrieved 2011-12-10.
- ↑ "International Melanoma Tissue Bank in the Works". Cure Today. Retrieved 2023-02-24.
- ↑ "Cancer Immunotherapy Partnerships and Collaborations". Society for Immunotherapy of Cancer. Archived from the original on 2023-05-10. Retrieved 2023-05-10.
- ↑ "US Medical, Scientific, Patient and Civic Organization Funding Report: Q1-Q2 2021" (PDF). Pfizer. 2021-09-27. Archived (PDF) from the original on 2023-05-03. Retrieved 2023-05-10.
- ↑ "Our Industry Partners". AIM at Melanoma Foundation. Archived from the original on 2023-05-10. Retrieved 2023-05-11.
External links
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.